OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GALT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Galectin Therapeutics (GALT) Earnings Date & Reports

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GALT is expected to report earnings to rise 26.67% to -18 cents per share on August 18

Galectin Therapeutics GALT Stock Earnings Reports

Q2'25

Est.

$-0.19

Q1'25

Beat

by $0.05

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.04

The last earnings report on May 15 showed earnings per share of -15 cents, beating the estimate of -20 cents. With 361.68K shares outstanding, the current market capitalization sits at 241.77M.

View a ticker or compare two or three

Compare

GALT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GALT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GALT showed earnings on May 15, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4960 Peachtree Industrial Boulevard

Phone

+1 678 620-3186

Employees

Web

https://www.galectintherapeutics.com